If this message is not displayed correctly, please click here.

What's up at IZB

Dear Mister/Miss Titel ,

Looking back and looking ahead - this is the motto of our latest newsletter. On May 22, we celebrated the 30th anniversary of the IZB together with around 160 guests, including Bavaria's Minister President Dr. Markus Söder and Secretary of State Tobias Gotthardt. If you couldn't attend in person (or if you want to relive the highlights), you can find a video with moments from the celebration on our website – definitely worth a look! The true stars at IZB are our start-ups. I am especially pleased that the German Press Agency (dpa) featured profiles of five of our companies, thereby garnering widespread media attention.

The newsletter also contains exciting news from the IZB: from the arrival of the company RNhale to the successful financing round of AATec Medical. At the next IZBrunch on Tuesday, July 8, you can find out first-hand how the funds are driving the development of innovative therapies for respiratory diseases. Prof. Dr. Markus Diefenbacher (LMU/Helmholtz) and Dr. Rüdiger Jankowsky, CEO of AATec Medical, will be speaking on the topic: “Perspectives for the respiratory tract”.


Best regards,

Christian Gnam
Managing Director IZB
IZB News
Excerpt from the article in the tz

IZB
In the Spotlight: dpa Features IZB Start-ups

Our founders are doing impressive work – and they deserve to be seen and heard.  That’s why we’re especially pleased that the German Press Agency (dpa) visited and profiled five IZB companies as representatives of our broader community.
The article received wide media coverage – including features in Süddeutsche Zeitung, Zeit online, tz, and on ntv..
IZB-based Biotech Startup AATec Medical Secures EUR 4 Million to Advance Novel Respiratory Therapy ATL-105.

AATec Medical
The Startup Secures EUR 4 Million to Advance Novel Respiratory Therapy ATL-105

SPRIND & Family Office funding accelerates preparations of AATec Medical’s ATL-105 towards clinical trials for non-CF bronchiectasis by 2026.
Momentum Biotechnologies Announces Acquisition of OmicScouts

OmicScouts
Momentum Biotechnologies Acquires OmicScouts to Advance Proteomics-Driven Drug Discovery

Momentum Biotechnologies Announces Acquisition of OmicScouts.
Dr. Wolfgang Hofmann, CEO leon-nanodrugs GmbH.

leon-nanodrugs
Strengthens Leadership Team with new CEO

Dr. Wolfgang Hofmann to lead leon-nanodrugs’ next phase of growth and the market launch of its FR-JET® technology
Protevo Bio develops scalable and cost-effective purification processes for proteins

Protevo Bio
Acquires Platform Technologies for Scalable Protein Production

With acquired know-how and innovative technology, Protevo Bio is entering a new era of scalable protein production.
Protevo Bio develops scalable and cost-effective purification processes for proteins

RNhale
New start-up at IZB

As of June, RNhale is a new member of our community at the IZB in Martinsried. The start-up was founded in 2023 as a spin-off from the Chair of Pharmaceutical Technology at LMU. Using a spray-drying-based process, RNhale formulates RNA-loaded lipid nanoparticles as an inhalable dry powder. This innovative method enables the manufacture of a drug product that can be administered directly to the lungs, remains remarkably stable at room temperature, and is suitable for large-scale production.
30 years of biotech innovation at the IZB

IZB
30 Years of IZB: An Interview with Christian Gnam

The Managing Director talks about the history of the Biotech Hub and his ideas for the future.
CAMPUS
Wolfgang Baumeister and Elena Conti, MPI of Biochemistry

MPI
Two Leading Scientists from the Max Planck Institute of Biochemistry Honored

Elena Conti and Wolfgang Baumeister receive prestigious awards.
EVENTS
Anniversary with a vision: 30 years of IZB

IZB
When Vision Meets History: 30 Years of IZB

Three decades of innovation, entrepreneurship, and biotech excellence were celebrated on May 22, 2025, on the IZB campus in Martinsried. Around 160 guests – including Bavarian Minister President Dr. Markus Söder – came together to honor the success story of the Innovation and Start-up Center for Biotechnology.
Where politics meets innovation

IZB
Business Reception at the IZB

Where politics meets innovation: Inspiring dialogue and fresh perspectives at the heart of biotechnology.
IZBrunch

IZBrunch
Save the date for the IZBrunch on July 8, 2025

Prof. Dr. Markus Diefenbacher (LMU/Helmholtz) and Dr. Rüdiger Jankowsky (AATec Medical) will speak on the topic "Perspectives on Respiratory Health."

Tuesday, July 8, 2025, at 10:45 a.m. at the IZB Faculty Club.
Register at 
Contact
Marion Köhler
Head of Public Relation
Phone: 089/55 279 48-17
Location
Martinsried
Fördergesellschaft IZB mbH
Am Klopferspitz 19
82152 Planegg / Martinsried
Location
Weihenstephan
Fördergesellschaft IZB mbH
Lise-Meitner-Straße 30
85354 Freising / Weihenstephan
If you don't want to receive any more messages (to: unknown@noemail.com), you can unsubscribe here free of charge at any time.
Fördergesellschaft IZB mbH
Christian Gnam
Am Klopferspitz, 19
82152 Planegg
Deutschland

+4989552794817
info@izb-online.de